<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Septic dural sinus thrombosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Septic dural sinus thrombosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Septic dural sinus thrombosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Frederick S Southwick, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Allan R Tunkel, MD, PhD, MACP
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Glenn A Tung, MD, FACR
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jennifer Mitty, MD, MPH
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Janet L Wilterdink, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 20, 2020.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H736911131">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Septic dural sinus thrombosis is an uncommon condition with only several hundred cases reported in the English medical literature during the antibiotic era. Since this disorder is rare, each clinician is likely to encounter only one or a few cases during his or her career. The combination of lack of familiarity and the myriad of potential symptoms and signs often leads to misinterpretation of the clinical manifestations.
        </p>
        <p>
         Dural sinus thrombosis includes three syndromes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Cavernous sinus thrombosis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lateral sinus thrombosis
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Superior sagittal sinus thrombosis
        </p>
        <p>
        </p>
        <p>
         All three syndromes result in severe headache, which is the most common complaint that brings the patient to the clinician. An exception is the older adult (over age 65 years) who may present with an alteration in mental status without antecedent headache [
         <a href="#rid1">
          1-3
         </a>
         ]. The other clinical manifestations of each syndrome reflect the anatomy of the specific sites.
        </p>
        <p>
         This topic discusses septic dural sinus thrombosis. Aseptic dural sinus thrombosis is discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1103.html" rel="external">
          "Cerebral venous thrombosis: Etiology, clinical features, and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1109.html" rel="external">
          "Cerebral venous thrombosis: Treatment and prognosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          SEPTIC CAVERNOUS SINUS THROMBOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The cavernous sinus is the most frequent dural sinus to become infected and thrombosed [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Anatomy
         </span>
         <span class="headingEndMark">
          —
         </span>
         The cavernous sinuses are the most centrally located of the dural sinuses, positioned just lateral to the base of the sella turcica and to the sphenoid paranasal sinuses. These irregularly shaped sinuses contain multiple trabeculae that act as sieves to trap bacteria; this characteristic explains the higher risk of infection of the cavernous sinuses as compared with the other dural sinuses. The cavernous sinuses are connected by two intercavernous sinuses that pass anteriorly and posteriorly to the sella turcica and the pituitary gland; thus bilateral infection is not uncommon, particularly if treatment is delayed.
        </p>
        <p>
         A number of cranial nerves are located within a dural sleeve, lateral to the cavernous sinus: oculomotor nerve (cranial nerve III), trochlear nerve (cranial nerve IV), and ophthalmic (V
         <sub>
          1
         </sub>
         ) and maxillary branches (V
         <sub>
          2
         </sub>
         ) of the trigeminal nerve (
         <a class="graphic graphic_figure graphicRef65634" href="/z/d/graphic/65634.html" rel="external">
          figure 1
         </a>
         ). The abducens nerve (cranial nerve VI) is located more medially within the cavernous sinus and abuts the cavernous segment of the internal carotid artery [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H965624159">
         <span class="h2">
          Pathogenesis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The cavernous sinuses receive blood from the facial veins and pterygoid plexus via the inferior and superior ophthalmic veins. Infections of the face, including the nose, orbits, tonsils, and soft palate, can spread to the cavernous sinus by this route.
        </p>
        <p>
         Three sites of primary infection are the most likely to lead to septic cavernous sinus thrombosis:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Sphenoid and/or ethmoid sinus infections
         </strong>
         have increasingly been reported with cavernous sinus thrombosis [
         <a href="#rid5">
          5
         </a>
         ]. Sphenoid sinusitis is the most common predisposing factor for cavernous sinus thrombosis [
         <a href="#rid6">
          6
         </a>
         ]. Infection can arise via the emissary veins or, in the case of sphenoid sinusitis, can spread by breaking through the porous lateral air sinus wall [
         <a href="#rid2">
          2,7,8
         </a>
         ]. Sphenoid sinus infection is particularly difficult to diagnose, and treatment is often delayed, providing time for the infection to spread to the cavernous sinus [
         <a href="#rid7">
          7
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6871.html" rel="external">
          "Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Ethmoid sinus infection can extend laterally to the orbit and subsequently spread to the cavernous sinus via the superior ophthalmic vein.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Facial infections
         </strong>
         are implicated in septic cavernous sinus thrombosis, especially those that involve the so-called danger zone (medial third of the face [ie, the areas around the nose]) that drains into the ophthalmic veins (
         <a class="graphic graphic_figure graphicRef55404" href="/z/d/graphic/55404.html" rel="external">
          figure 2
         </a>
         ). Nasal furuncles are the most common facial infection to produce this complication, particularly if the furuncle is squeezed or drained in the absence of antibiotic coverage [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Dental infection
         </strong>
         less commonly results in this complication; infection spreads to the cavernous sinus via the pterygoid venous plexus [
         <a href="#rid9">
          9
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3417.html" rel="external">
          "Epidemiology, pathogenesis, and clinical manifestations of odontogenic infections"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Otitis media and mastoiditis
         </strong>
         – Otitis media and its related complication, mastoiditis, rarely result in cavernous sinus disease despite the frequency of these infections as a cause in the pre-antibiotic era [
         <a href="#rid5">
          5,10,11
         </a>
         ]. Mastoid infection can spread first to the lateral and sigmoid sinuses before reaching the cavernous sinuses via the inferior and superior petrosal sinuses. Infection can spread in a retrograde direction in this manner, depending upon the pressure gradients, because the dural sinuses contain no valves.
        </p>
        <p>
        </p>
        <p>
         Conditions that cause immunosuppression (eg, diabetes, chronic alcohol abuse, long-term glucocorticoid therapy) may be risk factors for septic cavernous sinus thrombosis [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H4111136165">
         <span class="h2">
          Microbiology
         </span>
         <span class="headingEndMark">
          —
         </span>
         The organisms associated with septic cavernous sinus thrombosis reflect the primary sites of infection as outlined above [
         <a href="#rid2">
          2,12-14
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Staphylococcus aureus
         </em>
         accounts for 70 percent of all infections and is the etiologic pathogen in nearly all cases associated with facial infection or sphenoid sinusitis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Community-acquired methicillin-resista
         <em>
          nt S. aureus
         </em>
         (MRSA) is reported with increasing frequency [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Streptococci (including
         <em>
          S. pneumoniae
         </em>
         ,
         <em>
          S. milleri
         </em>
         , and viridans group streptococci) are less commonly found.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Anaerobes are occasionally cultured, including
         <em>
          Bacteroides
         </em>
         spp and
         <em>
          Fusobacterium
         </em>
         spp, and are most often found with accompanying sinus, dental, or tonsillar infections.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fungal pathogens are less commonly reported and include
         <em>
          Rhizopus sp
         </em>
         p [
         <a href="#rid2">
          2,16,17
         </a>
         ] and other agents of mucormycosis [
         <a href="#rid18">
          18
         </a>
         ],
         <em>
          Aspergillus
         </em>
         spp [
         <a href="#rid19">
          19
         </a>
         ], and
         <em>
          Schizophyllum commune
         </em>
         [
         <a href="#rid20">
          20
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Clinical manifestations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Headache is the most common early symptom and generally precedes fever and periorbital edema by several days. The character of the headache is generally sharp; the pain progressively increases in severity, interferes with sleep, and is not relieved by pain medications. The pain is usually unilateral, involving the retro-orbital and frontal areas with occasional radiation to the occipital region [
         <a href="#rid2">
          2
         </a>
         ]. The severe nature of the headache is the most common reason for patients to seek medical attention. Clinicians frequently misdiagnose the pain as migraine headache when the patient presents early in the course of the disorder, before the onset of neurologic deficits.
        </p>
        <p>
         Patients often develop symptoms in addition to headache, including:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fever is present in most patients (94 percent according to one review) [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Eye swelling that begins as a unilateral process but within 24 to 48 hours spreads via the intercavernous sinuses to produce swelling in the other eye; in one series, this was reported in 73 percent of patients [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diplopia is a presenting complaint in some patients but is less common than documented oculomotor deficits on examination [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Alterations in mental status such as drowsiness, confusion, and coma can rapidly follow eye complaints, reflecting spread to the meninges. A depressed mental status occurs more commonly in older adult patients and in fatal cases [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         In typical patients, symptoms progress over a few to several days. Rarely, cavernous sinus infection can be a subacute or chronic process, in which headache can be present for several months prior to the onset of eye findings [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
         Less common complaints include photophobia and eye tearing [
         <a href="#rid2">
          2
         </a>
         ]. Rare complications include seizures, stroke, and hypopituitarism [
         <a href="#rid21">
          21
         </a>
         ]. Loss of visual acuity can arise from optic nerve involvement. Blindness caused by compression of the optic nerve by a mycotic aneurysm of the intercavernous segment of the internal carotid/ophthalmic artery has been reported [
         <a href="#rid22">
          22
         </a>
         ]. These uncommon complications are more common when treatment is delayed but can occur on antimicrobial therapy.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Evaluation and diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The early symptoms of septic cavernous sinus thrombosis are not specific, but the presence of cranial nerve signs (particularly lateral gaze palsy) on physical examination in a patient with headache should alert the clinician to the possibility of cavernous sinus involvement and prompt imaging studies, which are in most cases diagnostic. The evaluation should proceed promptly, as delays to treatment may be associated with morbidity and mortality.
        </p>
        <p class="headingAnchor" id="H4261459145">
         <span class="h3">
          Physical examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         When cavernous sinus septic thrombosis is fully manifest, the majority of patients present with fever and the classic constellation of bilateral ptosis, proptosis, chemosis, and ocular muscle paralysis. However, the physical findings may be considerably subtler when patients present earlier in the disease course. A careful eye and neurologic examination, with particular attention to the cranial nerves, is necessary in order to make a diagnosis at an earlier stage.
        </p>
        <p>
         Periorbital edema may be the earliest physical finding and should prompt a more detailed examination in patients with headache:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Funduscopic exam is abnormal in two-thirds of patients. Papilledema or dilated tortuous retinal veins are noted in almost two-thirds of patients [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Extraocular muscle weakness is an important finding present in 50 to 88 percent of cases [
         <a href="#rid2">
          2,3
         </a>
         ] and results from dysfunction of cranial nerves III, IV, and VI. The following signs should be sought:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Lateral gaze palsy (isolated cranial nerve VI [abducens] dysfunction) may precede full-blown ophthalmoplegia, particularly in cases of chronic sphenoid sinusitis.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Drooping of the eyelid (ptosis), dilation of the pupil (mydriasis), and eye muscle weakness result from cranial nerve III dysfunction. Total palsy of the nerve leads to an eye that is facing down and lateral.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Exophthalmos (anterior bulging of the eye) and chemosis (conjunctival edema) are thought to result from occlusion of the ophthalmic veins and generally occur just before or at the same time as ophthalmoplegia. One or both of these findings is present in most patients [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hypo- or hyperesthesia in the dermatomes served by the ophthalmic (V
         <sub>
          1
         </sub>
         ) and maxillary (V
         <sub>
          2
         </sub>
         ) branches of the fifth cranial nerve (trigeminal nerve) can be subtle [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1156347151">
         <span class="h3">
          Imaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         In patients presenting with headache and cranial nerve signs localized to the cavernous sinus, a diagnostic neuroimaging study is urgent.
         <em>
         </em>
         Contrast-enhanced magnetic resonance imaging (MRI) and magnetic resonance venography are the imaging tests of choice and have been reported to be superior to computed tomography (CT), because MRI can detect all stages of thrombus in septic cavernous sinus thrombosis (
         <a class="graphic graphic_diagnosticimage graphicRef129666" href="/z/d/graphic/129666.html" rel="external">
          image 1
         </a>
         ) [
         <a href="#rid6">
          6
         </a>
         ]. If MRI is not readily available, high-resolution orbital CT with contrast can also demonstrate septic cavernous thrombosis [
         <a href="#rid23">
          23,24
         </a>
         ]. The early venous phase following administration of contrast demonstrates thickened cavernous sinus walls and decreased or irregular intrasinus enhancement (
         <a class="graphic graphic_diagnosticimage graphicRef129667" href="/z/d/graphic/129667.html" rel="external">
          image 2
         </a>
         ) [
         <a href="#rid25">
          25,26
         </a>
         ].
        </p>
        <p>
         MRI and CT can also simultaneously detect associated paranasal sinus infection. The presence of paranasal sinus infection should prompt consultation for possible surgical intervention. (See
         <a class="local">
          'Surgery'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2145379195">
         <span class="h3">
          Blood cultures and other studies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Two sets of blood cultures should be sent prior to initiation of antibiotics, and they are positive in approximately 70 percent of cases [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         The peripheral white blood cell count (WBC) is commonly elevated, suggesting an acute bacterial infection.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h3">
          Lumbar puncture
         </span>
         <span class="headingEndMark">
          —
         </span>
         A lumbar puncture is typically not performed unless there is concern that the patient has developed a complicating meningitis. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
         When performed, lumbar puncture reveals inflammatory cells in 75 percent of cases. In half of these cases, the cerebrospinal fluid (CSF) profile is most suggestive of a parameningeal focus (elevated WBC with a predominance of polymorphonuclear neutrophils [PMNs] and/or mononuclear cells, normal glucose, elevated or occasionally normal protein, and negative culture). In one-third of patients, the CSF profile is identical to that found in bacterial meningitis (elevated WBC with a predominance of PMN, low glucose, high protein, culture positive) [
         <a href="#rid2">
          2,16
         </a>
         ]. In rare patients, the CSF profile is normal.
        </p>
        <p>
         If a lumbar puncture is performed, Gram stain and culture should be performed; however, the CSF culture is rarely positive [
         <a href="#rid6">
          6
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2093431073">
         <span class="h2">
          Differential diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of conditions are considered in the differential diagnosis of septic cavernous sinus thrombosis, including those that are considered in the differential diagnosis of painful ophthalmoplegia (
         <a class="graphic graphic_table graphicRef77825" href="/z/d/graphic/77825.html" rel="external">
          table 1
         </a>
         ). Signs of orbital congestion (proptosis, conjunctival injection, and chemosis) usually accompany diseases involving the orbit. Most of these can be distinguished by neuroimaging evaluation and/or clinical symptoms. Among the more common conditions to consider are:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Orbital cellulitis
         </strong>
         – Orbital cellulitis and septic cavernous sinus thrombosis have overlapping symptoms including periorbital eye swelling, chemosis, and ophthalmoplegia. Also, in rare cases, septic cavernous sinus thrombosis is a complication of orbital cellulitis (see
         <a class="medical medical_review" href="/z/d/html/3414.html" rel="external">
          "Orbital cellulitis", section on 'Clinical manifestations'
         </a>
         ). Clinical characteristics that increase the probability of involvement of the cavernous sinus include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Dilated pupil or pupils
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Visual loss
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Papilledema
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Fifth cranial nerve dysfunction
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Bilateral eye involvement
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Inflammatory cells in the CSF
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         High-resolution CT or MRI can readily differentiate between the two diseases by demonstrating involvement of the cavernous sinus. (See
         <a class="local">
          'Imaging'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Intraorbital abscess
         </strong>
         – This typically presents acutely with periorbital swelling, proptosis, chemosis, ophthalmoplegia, fever, decreased vision, and pain; however, it usually has an absence of papilledema and papillary involvement. Imaging studies are able to differentiate abscess from cavernous sinus thrombosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Intracavernous carotid artery aneurysm or arteriovenous fistula
         </strong>
         – These entities are often accompanied by proptosis, pain with a pulsatile feeling, bruit, and engorgement of blood vessels. Patients do not have fever or other signs of infection. Neuroimaging findings are distinctive. (See
         <a class="medical medical_review" href="/z/d/html/14161.html" rel="external">
          "Carotid-cavernous fistulas", section on 'Diagnosis and imaging findings'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Neoplastic or inflammatory infiltration of the cavernous sinus
         </strong>
         from meningioma or metastasis, as well as neurosarcoid, IgG4-related disease, idiopathic pachymeningitis or granulomatosis with polyangiitis, and Tolosa-Hunt syndrome. These can present with headache, periorbital pain and external ophthalmoplegia; however, fever is usually mild or absent. (See
         <a class="medical medical_review" href="/z/d/html/5248.html" rel="external">
          "Tolosa-Hunt syndrome", section on 'Differential diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Aseptic cavernous sinus thrombosis
         </strong>
         –
         <strong>
         </strong>
         Septic cavernous sinus thrombosis is typically distinguished from aseptic disease by the presence of fever on examination as well as associated finding of infection in the sinus, mastoid, or face on imaging and/or examination. (See
         <a class="medical medical_review" href="/z/d/html/1103.html" rel="external">
          "Cerebral venous thrombosis: Etiology, clinical features, and diagnosis", section on 'Syndromes associated with isolated sinus or vein thrombosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         The mainstay of therapy for septic cavernous sinus thrombosis is antibiotics; anticoagulation and surgery are appropriate adjunctive treatments in selected cases. Treatment should be started urgently as delays to treatment may be associated with morbidity and mortality.
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h3">
          Antibiotics
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intravenous (IV) antibiotics should be instituted emergently and directed at the probable organisms causing this type of infection. (See
         <a class="local">
          'Microbiology'
         </a>
         above.)
        </p>
        <p>
         The regimens listed below are for patients with normal renal function. Dose adjustments for patients with reduced kidney function can be found in the Lexicomp drug information topics within UpToDate.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Empiric and directed regimens
         </strong>
         –
         <strong>
         </strong>
         Empiric therapy should include coverage for community-acquired MRSA. Appropriate empiric parenteral regimens include:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">
          Vancomycin
         </a>
         (
         <a class="graphic graphic_table graphicRef128911" href="/z/d/graphic/128911.html" rel="external">
          table 2
         </a>
         );
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         PLUS EITHER:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">
          Ceftriaxone
         </a>
         (2 g IV every 12 hours);
         <strong>
          OR
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <a class="drug drug_general" data-topicid="9215" href="/z/d/drug information/9215.html" rel="external">
          Cefepime
         </a>
         (2 g IV every 8 to 12 hours). Cefepime (2 g IV every eight hours) should be used if
         <em>
          Pseudomonas
         </em>
         coverage is desired (eg, in patients with chronic sinusitis and known colonization of the sinus with pseudomonas).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Anaerobic coverage should be added if a dental or sinus infection is suspected. IV
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         (500 mg every six to eight hours) is highly effective for this purpose.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If a cephalosporin or
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         (if indicated) cannot be used, the combination of
         <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">
          vancomycin
         </a>
         (
         <a class="graphic graphic_table graphicRef128911" href="/z/d/graphic/128911.html" rel="external">
          table 2
         </a>
         ) and
         <a class="drug drug_general" data-topicid="9613" href="/z/d/drug information/9613.html" rel="external">
          meropenem
         </a>
         (2 g IV every eight hours) is a reasonable empiric regimen for most patients. If meropenem is not available,
         <a class="drug drug_general" data-topicid="8553" href="/z/d/drug information/8553.html" rel="external">
          imipenem
         </a>
         (1 g IV every six hours) can be used; however, we prefer meropenem since imipenem may increase the risk of seizures. Patients with severe beta-lactam allergies (eg, Stevens Johnson syndrome) may require a different regimen. (See
         <a class="medical medical_review" href="/z/d/html/100191.html" rel="external">
          "Penicillin allergy: Delayed hypersensitivity reactions"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2087.html" rel="external">
          "Allergy evaluation for immediate penicillin allergy: Skin test-based diagnostic strategies and cross-reactivity with other beta-lactam antibiotics"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13536.html" rel="external">
          "Immediate cephalosporin hypersensitivity: Allergy evaluation, skin testing, and cross-reactivity with other beta-lactam antibiotics"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13535.html" rel="external">
          "Cephalosporin hypersensitivity: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Antifungal therapy is rarely required and should only be utilized if invasive fungal infection is proven by biopsy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If susceptibility testing reveals methicillin-susceptible
         <em>
          S. aureus
         </em>
         , therapy should be changed to
         <a class="drug drug_general" data-topicid="9674" href="/z/d/drug information/9674.html" rel="external">
          nafcillin
         </a>
         (2 g IV every four hours) or
         <a class="drug drug_general" data-topicid="9724" href="/z/d/drug information/9724.html" rel="external">
          oxacillin
         </a>
         (2 g IV every four hours). First-generation cephalosporins (eg,
         <a class="drug drug_general" data-topicid="9214" href="/z/d/drug information/9214.html" rel="external">
          cefazolin
         </a>
         ) should be avoided for treatment of central nervous system infections because of poor CSF penetration.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If the organism is methicillin resistant
         <em>
          S. aureus
         </em>
         ,
         <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">
          vancomycin
         </a>
         should be continued (
         <a class="graphic graphic_table graphicRef128911" href="/z/d/graphic/128911.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid27">
          27-29
         </a>
         ]. If vancomycin cannot be used or is ineffective based on a lack of improvement of clinical manifestations (eg, fever, bacteremia, changes in mental status) over the course of seven days, reasonable alternatives include
         <a class="drug drug_general" data-topicid="16088" href="/z/d/drug information/16088.html" rel="external">
          ceftaroline
         </a>
         (600 mg IV every 8 to 12 hours) [
         <a href="#rid30">
          30
         </a>
         ],
         <a class="drug drug_general" data-topicid="9304" href="/z/d/drug information/9304.html" rel="external">
          daptomycin
         </a>
         (6 to 10 mg/kg IV once daily),
         <a class="drug drug_general" data-topicid="10283" href="/z/d/drug information/10283.html" rel="external">
          linezolid
         </a>
         (600 mg IV or orally twice daily) [
         <a href="#rid15">
          15,31-33
         </a>
         ], and
         <a class="drug drug_general" data-topicid="9785" href="/z/d/drug information/9785.html" rel="external">
          trimethoprim-sulfamethoxazole
         </a>
         (5 mg/kg [based on the
         <a class="drug drug_general" data-topicid="10024" href="/z/d/drug information/10024.html" rel="external">
          trimethoprim
         </a>
         component] IV every 8 to 12 hours) [
         <a href="#rid34">
          34-36
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Duration
         </strong>
         –
         <strong>
         </strong>
         Because thrombus may limit the penetration of antibiotics, prolonged IV antibiotics are recommended. A minimum of three weeks of treatment is generally required to assure sterilization. The duration may need to be extended longer based upon the presence of other factors, such as bacteremia with
         <em>
          S. aureus
         </em>
         (see
         <a class="medical medical_review" href="/z/d/html/2134.html" rel="external">
          "Clinical approach to Staphylococcus aureus bacteremia in adults", section on 'Completing antibiotic therapy'
         </a>
         ) or if significant ophthalmoplegia or edema of the eye remains at the end of planned therapy. We use clinical rather than imaging parameters to guide this decision, as improvement in imaging is often delayed.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h3">
          Anticoagulation
         </span>
         <span class="headingEndMark">
          —
         </span>
         We suggest immediate anticoagulation in patients with unilateral cavernous sinus thrombosis in order to prevent bilateral extension. This practice is based on limited and conflicting data. For patients with bilateral disease, we do not use anticoagulation.
        </p>
        <p>
         For patients treated with anticoagulation, we suggest continuous-infusion heparin anticoagulation, adjusting the dose to maintain a partial thromboplastin time ratio of 1.5 to 2.5 [
         <a href="#rid37">
          37
         </a>
         ]. There are no reports of low-molecular-weight heparin being used in this setting; however, hemorrhagic complications have been observed in two patients who were receiving low-molecular-weight heparin for septic lateral sinus thrombosis (see
         <a class="local">
          'Septic lateral sinus thrombosis'
         </a>
         below).
         <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">
          Warfarin
         </a>
         should be avoided in the acute phase of the illness because of the difficulty in rigorously maintaining safe anticoagulation levels.
        </p>
        <p>
         The duration of anticoagulation has not been determined. We continue anticoagulation until the infection as well as the symptoms and signs of cavernous sinus thrombosis (eg, periorbital edema, fever, leukocytosis) have resolved or significantly improved.
        </p>
        <p>
         Although the use of anticoagulants in septic cavernous sinus thrombosis is controversial and there are limited data on this issue, one retrospective study observed a reduction in mortality in patients with unilateral involvement who presented early and who received heparin (14 percent) compared with those who did not receive heparin (36 percent) [
         <a href="#rid2">
          2
         </a>
         ]. In a second retrospective analysis, the addition of early anticoagulation to antibiotic treatment did not affect mortality but did decrease morbidity, including ophthalmoplegia, blindness, stroke, hypopituitarism, and seizures [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p>
         Complications associated with anticoagulation were rare. In another cohort of 57 patients who had central nervous system venous thrombosis associated with head or neck infections, use of heparin was not associated with an increase in intracranial hemorrhage in patients receiving heparin compared with patients not receiving heparin (26 versus 25 percent) [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h3">
          Surgery
         </span>
         <span class="headingEndMark">
          —
         </span>
         Surgical drainage of sphenoid sinus infection that has been documented on imaging should be strongly considered and, if done, should be performed emergently [
         <a href="#rid39">
          39
         </a>
         ]. Debridement of the infected sphenoid can be followed by rapid improvement. Although controlled studies are lacking, the improved mortality from this condition over the past decade is likely attributable in part to improved imaging and earlier surgical drainage [
         <a href="#rid40">
          40
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3939231452">
         <span class="h3">
          Lack of role for glucocorticoids
         </span>
         <span class="headingEndMark">
          —
         </span>
         We do not favor the use of glucocorticoids for septic cavernous sinus thrombosis.
        </p>
        <p>
         There has been interest in using glucocorticoids in patients with septic cavernous sinus thrombosis to potentially reduce cranial nerve edema and orbital inflammation, but the limited data available suggest they are not useful [
         <a href="#rid37">
          37,41,42
         </a>
         ]. In one prospective observational study of 624 patients with cerebral venous thrombosis, poor outcome defined as death or dependence at six months was similar in patients treated with steroids compared with patients not treated with steroids (odds ratio 1.7; 95% CI 0.9 to 3.3) [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Outcome
         </span>
         <span class="headingEndMark">
          —
         </span>
         The overall mortality rate associated with septic cavernous sinus thrombosis has been reported to be 30 percent [
         <a href="#rid2">
          2
         </a>
         ]. An additional 30 percent of patients in that series suffered serious sequelae including persistent oculomotor weakness, blindness, hemiparesis, or pituitary insufficiency. The morbidity and mortality (50 percent, respectively) are particularly high in cases of cavernous sinus thrombosis associated with sphenoid sinus infection [
         <a href="#rid2">
          2,7
         </a>
         ]. More recent case series and reviews provide a small number of patients for analysis, but the prognosis appears to be more favorable, with estimated mortality rates of 9 to 16 percent and morbidity rates of 15 to 38 percent [
         <a href="#rid40">
          40,43
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h1">
          SEPTIC LATERAL SINUS THROMBOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lateral sinus thrombosis, a complication of acute or chronic otitis media, is now uncommon, except in developing countries [
         <a href="#rid44">
          44
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6021.html" rel="external">
          "Acute otitis media in children: Epidemiology, microbiology, and complications", section on 'Complications and sequelae'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Pathogenesis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lateral sinus thrombosis most often occurs as a complication of acute or chronic otitis media. If otitis media is not treated appropriately in a timely manner, the infection can spread to the mastoid and ultimately to the epidural space. Mastoid air cell infection can lead to thrombosis of the lateral sinus, which may then propagate to the internal jugular vein and other dural sinuses [
         <a href="#rid2">
          2,45,46
         </a>
         ].
        </p>
        <p>
         Interruption of venous circulation may lead to increased intracranial pressure [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
         Septic pulmonary embolism may also occur as a complication of lateral sinus thrombosis [
         <a href="#rid47">
          47-49
         </a>
         ].
        </p>
        <p>
         In children, hypercoagulable conditions appear to be a risk factor. Although the magnitude of this risk has not been quantified systematically, in one series of septic dural sinus thrombosis in the setting of otitis media, more than 70 percent had a prothrombotic condition [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3715519246">
         <span class="h2">
          Microbiology
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infection is often polymicrobial, containing both aerobes and anaerobes. The principal pathogens associated with this complication reflect the bacteriology of chronic otitis media. Traditionally,
         <em>
          Proteus
         </em>
         spp have been most common, followed by
         <em>
          S. aureus
         </em>
         ,
         <em>
          Escherichia coli
         </em>
         , and anaerobes (
         <em>
          Bacteroides fragilis
         </em>
         and anaerobic streptococci) [
         <a href="#rid2">
          2
         </a>
         ]; however, more recent case series suggest that streptococcal infections are increasing in incidence [
         <a href="#rid51">
          51
         </a>
         ].
         <em>
          Pseudomonas
         </em>
         has been identified as a pathogen in intraoperative cultures in a few cases; however, when
         <em>
          Pseudomonas
         </em>
         is cultured from the external ear canal,
         <em>
         </em>
         it cannot be assumed that this is the infecting organism [
         <a href="#rid45">
          45,52
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h2">
          Clinical manifestations
         </span>
         <span class="headingEndMark">
          —
         </span>
         Septic lateral sinus thrombosis has a subacute onset. Symptoms generally begin several weeks before presentation and reflect the underlying infection as well as the development of septic lateral sinus thrombosis.
        </p>
        <p class="headingAnchor" id="H2761159527">
         <span class="h3">
          Symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         Symptoms include [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Earache is generally the first symptom, persisting for several weeks prior to the onset of headache.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Headache is generally severe, persistent, and localized to the side of the ear infection. Pain is thought to be a manifestation of a developing epidural abscess, irritation of the fifth cranial nerve, or thrombosis of the lateral sinus. (See
         <a class="medical medical_review" href="/z/d/html/103898.html" rel="external">
          "Intracranial epidural abscess"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nausea and vomiting develop in nearly half of cases and can be mistaken for severe gastroenteritis. This manifestation may reflect irritation of brainstem nuclei or cranial nerves, or elevated cerebrospinal fluid (CSF) pressure.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other symptoms include vertigo, diplopia, photophobia, and neck pain and stiffness.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Less commonly, patients can present with headache and neurologic manifestations in the absence of ear pain and have radiologic findings consistent with chronic otitis media that may be accompanied by a cholesteatoma [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Some patients develop cough productive of bloody sputum that results from septic pulmonary emboli, an uncommon complication of lateral sinus thrombosis [
         <a href="#rid49">
          49
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h3">
          Physical findings
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fever is present in 80 percent of cases, and patients often appear ill [
         <a href="#rid2">
          2
         </a>
         ]. High-spiking "picket" fence fevers are considered characteristic [
         <a href="#rid46">
          46
         </a>
         ]; however, fever may be less prominent in those associated with chronic otitis media [
         <a href="#rid51">
          51
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         An abnormal ear examination is found in most patients; 40 percent have a ruptured tympanic membrane and 20 percent have a dull, erythematous tympanic membrane [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Posterior auricular swelling is found in over half of the cases and is caused by occlusion of the mastoid emissary veins. This finding is called the Griesinger sign and is considered pathognomonic for septic lateral sinus thrombosis [
         <a href="#rid46">
          46
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bilateral papilledema (the result of elevated CSF pressure) is also present in half of the cases and may be associated with retinal hemorrhage [
         <a href="#rid2">
          2
         </a>
         ]. Accompanying loss of visual acuity develops in 15 percent.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Unilateral sixth nerve dysfunction is reported in over a third of cases and is thought to be caused by compression of the nerve by swelling of the inferior petrosal sinus within the closed space of Dorello canal [
         <a href="#rid2">
          2,51
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Otitis media, sixth nerve paralysis, and fifth cranial nerve irritation (temporoparietal and retroorbital pain) are known as Gradenigo syndrome. This is rare, but when present, this symptom complex provides strong evidence for lateral sinus thrombosis or inflammation of the petrous ridge of the temporal bone [
         <a href="#rid54">
          54,55
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nuchal rigidity is present in one-third to one-half of patients and is probably the result of meningeal inflammation [
         <a href="#rid2">
          2,51
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Depression in mental status is noted in 14 percent of cases.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1950897063">
         <span class="h3">
          Imaging findings
         </span>
         <span class="headingEndMark">
          —
         </span>
         Mastoid radiographs are abnormal in all patients with septic lateral sinus thrombosis, showing increased density with loss of mastoid trabeculae, bony sclerosis, and lytic lesions of the temporal and parietal bones.
        </p>
        <p>
         Otomastoid infection can be confirmed on either computed tomography (CT) or enhanced magnetic resonance imaging (MRI). Contrast-enhanced CT or MRI with venography (CTV or MRV) detect filling defects from thrombi and absent flow in the dural sinus, respectively, in patients with septic lateral sinus thrombosis (
         <a class="graphic graphic_diagnosticimage graphicRef129668" href="/z/d/graphic/129668.html" rel="external">
          image 3
         </a>
         ). Three-dimensional magnetic resonance gradient-echo cerebral venography has been shown to be superior to two-dimensional magnetic resonance [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p>
         Chest radiography rarely reveals rounded densities. These lesions are caused by septic emboli passing from the lateral sinus into the internal jugular vein and then passing into the pulmonary venous circulation.
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h2">
          Evaluation and diagnosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of septic lateral sinus thrombosis should be suspected in a patient with otitis media who develops headache and neurologic signs such as vertigo and diplopia. Either contrast-enhanced MR with MRV or contrast-enhanced CT with CTV should be performed and will confirm the diagnosis, differentiating this from other complications including mastoiditis and abscess formation. (See
         <a class="local">
          'Imaging findings'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/15312.html" rel="external">
          "Chronic otitis media and cholesteatoma in adults"
         </a>
         .)
        </p>
        <p>
         Lumbar puncture and opening pressure measurement should be performed in all cases after MRI or CT has excluded the possibility of brain abscess. CSF pressures are commonly elevated to the range of 450 to 500 mm H
         <sub>
          2
         </sub>
         O in 75 percent of cases. Increased CSF pressure results from interference with CSF resorption by arachnoid villi draining into the superior sagittal sinus. The CSF analysis is normal in two-thirds of cases and reflects parameningeal inflammation in the other third. CSF should be sent for Gram stain and culture.
        </p>
        <p>
         Two sets of blood cultures should be sent prior to initiation of antibiotics.
        </p>
        <p>
         We do not routinely evaluate patients for hypercoagulable conditions, particularly in the typical setting in which there is a documented otitis which explains the occurrence of thrombosis. However, case series in pediatric patients suggest that between one-third to one-half of children may be found to have a hypercoagulable condition when tested [
         <a href="#rid57">
          57,58
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H25">
         <span class="h2">
          Treatment
         </span>
         <span class="headingEndMark">
          —
         </span>
         The mainstays of treatment of septic lateral sinus thrombosis are antibiotics and, in the absence of rapid defervescence, surgery.
        </p>
        <p class="headingAnchor" id="H26">
         <span class="h3">
          Antibiotics
         </span>
         <span class="headingEndMark">
          —
         </span>
         Intravenous (IV) antibiotics need to be administered immediately [
         <a href="#rid2">
          2,59,60
         </a>
         ]. The regimens listed below are for patients with normal renal function. Dose adjustments for patients with reduced kidney function can be found in the Lexicomp drug information topics within UpToDate.
        </p>
        <p>
         An appropriate empiric parenteral regimen includes:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">
          Ceftriaxone
         </a>
         2 g IV every 12 hours OR
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9215" href="/z/d/drug information/9215.html" rel="external">
          Cefepime
         </a>
         2 g IV every 8 to 12 hours
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         AND
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          Metronidazole
         </a>
         500 mg IV every six to eight hours
        </p>
        <p>
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9215" href="/z/d/drug information/9215.html" rel="external">
          Cefepime
         </a>
         (2 g IV every eight hours) plus IV
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         should be used if
         <em>
          Pseudomonas
         </em>
         is suspected (eg, patients with chronic otitis media and known colonization with
         <em>
          Pseudomonas
         </em>
         ).
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9613" href="/z/d/drug information/9613.html" rel="external">
          Meropenem
         </a>
         (2 g IV every eight hours) is an acceptable alternative to one of the above regimens for most patients and is also active against
         <em>
          Pseudomonas
         </em>
         . If meropenem is not available,
         <a class="drug drug_general" data-topicid="8553" href="/z/d/drug information/8553.html" rel="external">
          imipenem
         </a>
         (1 g IV every six hours) can be used, but if both agents are available, we prefer meropenem since imipenem may increase the risk of seizures. Patients with severe beta-lactam allergies (eg, Stevens Johnson syndrome) may require a different regimen. (See
         <a class="medical medical_review" href="/z/d/html/100191.html" rel="external">
          "Penicillin allergy: Delayed hypersensitivity reactions"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2087.html" rel="external">
          "Allergy evaluation for immediate penicillin allergy: Skin test-based diagnostic strategies and cross-reactivity with other beta-lactam antibiotics"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13536.html" rel="external">
          "Immediate cephalosporin hypersensitivity: Allergy evaluation, skin testing, and cross-reactivity with other beta-lactam antibiotics"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13535.html" rel="external">
          "Cephalosporin hypersensitivity: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
         Methicillin-resistant
         <em>
          S. aureus
         </em>
         (MRSA) is rare in patients with septic lateral sinus thrombosis; however, the empiric addition of
         <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">
          vancomycin
         </a>
         (
         <a class="graphic graphic_table graphicRef128911" href="/z/d/graphic/128911.html" rel="external">
          table 2
         </a>
         ) is typically warranted in those who have had MRSA detected in prior cultures of the mastoid and in those who are acutely ill. (See
         <a class="medical medical_review" href="/z/d/html/484.html" rel="external">
          "Vancomycin: Parenteral dosing, monitoring, and adverse effects in adults"
         </a>
         .)
        </p>
        <p>
         If an organism is identified based upon cultures from myringotomy or intraoperative specimens, therapy should be changed to target the identified organisms based upon their antibiotic sensitivities.
        </p>
        <p>
         Three to four weeks of antibiotics are generally recommended, as mastoiditis is the most common primary infection; if the infection has been resected, a shorter duration of 10 to 14 days may be sufficient. We typically document resolution of the thrombosis with imaging.
        </p>
        <p class="headingAnchor" id="H27">
         <span class="h3">
          Surgery
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients diagnosed with lateral sinus thrombosis should have an urgent surgical consult [
         <a href="#rid51">
          51,61,62
         </a>
         ]. Radical mastoidectomy should be strongly considered in all patients who fail to defervesce within 12 to 24 hours of the initiation of antibiotic treatment. The basis for this recommendation is the understanding that mortality rates were substantial prior to the institution of this practice. No studies provide comparative outcome data.
        </p>
        <p>
         During surgery, the area overlying the lateral sinus should be explored so that infected granulation tissue or purulent collections can be drained and sent for culture. Removal of thrombus from the lateral sinus is considered in some cases; however, recanalization or the development of collateral venous drainage can occur without this intervention once the infection has been controlled [
         <a href="#rid51">
          51,63,64
         </a>
         ]. Ligation of the jugular vein, a common procedure in the preantibiotic era, is not recommended in most cases [
         <a href="#rid51">
          51
         </a>
         ].
        </p>
        <p>
         Not all cases of lateral sinus thrombosis require mastoidectomy with drainage. In one pediatric series, three of five patients responded quickly to antibiotic therapy and myringotomy for the underlying otitis, fully recovering without more aggressive surgical intervention [
         <a href="#rid65">
          65
         </a>
         ]. However, in the absence of prompt defervescence, surgical intervention is recommended.
        </p>
        <p class="headingAnchor" id="H28">
         <span class="h3">
          Anticoagulation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Anticoagulation is not part of the routine management of septic lateral sinus thrombosis.
        </p>
        <p>
         Potential indications for anticoagulation include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Failure to improve clinically with extension of thrombosis despite antibiotics and surgical drainage
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with a documented hypercoagulable state
        </p>
        <p>
        </p>
        <p>
         The role of anticoagulation in septic lateral sinus thrombosis remains controversial. Although there may be a theoretic benefit, the stimulus precipitating thrombosis in septic cases is self-limited, resolving with antibiotic treatment, and thrombotic vessels often undergo recanalization without anticoagulation [
         <a href="#rid57">
          57
         </a>
         ].
        </p>
        <p>
         Also, anticoagulation carries a potential risk of intracerebral hemorrhage. One case series describes a patient with septic lateral sinus thrombosis and cortical vein thrombosis who suffered a fatal hemorrhage while receiving
         <a class="drug drug_general" data-topicid="10050" href="/z/d/drug information/10050.html" rel="external">
          warfarin
         </a>
         [
         <a href="#rid2">
          2
         </a>
         ]. Hemorrhagic complications have been reported in at least three patients who were receiving low-molecular-weight heparin for septic lateral sinus thrombosis [
         <a href="#rid49">
          49,66
         </a>
         ]. Such cases are anecdotal, and the magnitude of the risk is unclear [
         <a href="#rid49">
          49
         </a>
         ]. In somewhat related patient populations, the risk appears to be low. As an example, in a report of patients with cerebral venous thrombosis associated with head and neck infections, there was no increased risk of intracranial hemorrhage associated with heparin therapy [
         <a href="#rid38">
          38
         </a>
         ]. The risk of hemorrhagic complications in patients with acute aseptic dural sinus thrombosis who receive anticoagulation appears to be low. (See
         <a class="medical medical_review" href="/z/d/html/1109.html" rel="external">
          "Cerebral venous thrombosis: Treatment and prognosis", section on 'Risk of new intracranial hemorrhage'
         </a>
         .)
        </p>
        <p>
         If anticoagulation is started, the duration is unclear. Neuroimaging can be used to document persistence or resolution of the thrombosis to guide treatment decisions. If a hypercoagulable state is documented, anticoagulation should be continued for at least six months [
         <a href="#rid53">
          53
         </a>
         ]. Prolonged anticoagulation should also be maintained for pediatric patients whose lateral sinus fails to recannulate [
         <a href="#rid53">
          53
         </a>
         ]. For others, anticoagulation can be continued until the infection as well as the symptoms and signs of lateral sinus thrombosis have resolved or significantly improved. (See
         <a class="medical medical_review" href="/z/d/html/1109.html" rel="external">
          "Cerebral venous thrombosis: Treatment and prognosis", section on 'Long-term anticoagulation'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H29">
         <span class="h3">
          Treatment of elevated intracranial pressure
         </span>
         <span class="headingEndMark">
          —
         </span>
         For patients with elevated intracranial pressure, serial lumbar punctures every 48 hours and/or ventricular drain may be required to lower the CSF pressure and relieve papilledema. Persistent communicating hydrocephalus may require placement of a ventricular shunt. Follow-up imaging and intervention should be guided by the patient's clinical examination, especially their level of consciousness. (See
         <a class="medical medical_review" href="/z/d/html/1659.html" rel="external">
          "Evaluation and management of elevated intracranial pressure in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H30">
         <span class="h2">
          Outcome
         </span>
         <span class="headingEndMark">
          —
         </span>
         The outcome is usually favorable in this disease, with a reported mortality of less than 1 percent in the past decade [
         <a href="#rid2">
          2,67
         </a>
         ]
         <em>
          .
         </em>
         The majority of patients fully recover, although 10 to 15 percent suffer chronic sequelae including hydrocephalus, decreased visual acuity, impaired hearing, and, rarely, residual hemiparesis [
         <a href="#rid62">
          62
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H31">
         <span class="h1">
          SEPTIC SUPERIOR SAGITTAL SINUS THROMBOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The superior sagittal sinus is the largest venous channel in the brain. In addition to arachnoid villi (responsible for cerebrospinal fluid resorption), multiple cortical veins empty into this venous channel [
         <a href="#rid2">
          2,4
         </a>
         ]. Given the large size of the superior sagittal sinus, septic thrombotic occlusion is very rare.
        </p>
        <p>
         The most common infection associated with complete occlusion of the superior sagittal sinus is bacterial meningitis. Thrombosis of the anterior segment has been associated with frontal bacterial sinusitis occasionally. Less common associations include facial plastic surgery and oral surgery [
         <a href="#rid68">
          68,69
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/1294.html" rel="external">
          "Epidemiology of community-acquired bacterial meningitis in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6871.html" rel="external">
          "Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis"
         </a>
         .)
        </p>
        <p>
         Septic thrombosis of the superior sagittal sinus results in hemorrhagic infarcts due to cortical vein thrombosis as well as in communicating hydrocephalus. When combined with the cerebral edema associated with meningitis, massive brain infarction in most cases quickly leads to transtentorial brainstem herniation [
         <a href="#rid70">
          70
         </a>
         ].
        </p>
        <p>
         Diagnosis is made most readily by gadolinium-enhanced magnetic resonance imaging (MRI) and MR venography (
         <a class="graphic graphic_diagnosticimage graphicRef129669" href="/z/d/graphic/129669.html" rel="external">
          image 4
         </a>
         ). As discussed above, this diagnostic technique readily demonstrates thrombus formation and decreased venous flow. As observed for lateral sinus thrombosis, three-dimensional MR has proved to be superior to two-dimensional MR angiography [
         <a href="#rid71">
          71
         </a>
         ].
        </p>
        <p>
         Antibiotics, if begun early for bacterial meningitis, can prevent this complication from occurring; however, once occlusion has occurred, initiation of antibiotics is unlikely to be of significant benefit for this complication. The treatment of bacterial meningitis is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/1290.html" rel="external">
          "Initial therapy and prognosis of community-acquired bacterial meningitis in adults"
         </a>
         .)
        </p>
        <p>
         The outcome of complete occlusion of the superior sagittal sinus is universally fatal. Occlusion of the anterior segment in association with frontal sinusitis presents with mild to moderate headache and spontaneously resolves following the development of collateral venous channels. Although anticoagulants and thrombolytic therapy are often administered in aseptic superior sagittal sinus thrombosis, their role in septic disease has not been defined, and, given the extensive intracerebral hemorrhage and the rapid progression to death, they are unlikely to be of benefit.
        </p>
        <p class="headingAnchor" id="H1319409772">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H1721476659">
         <span class="h2">
          Septic cavernous sinus thrombosis
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The cavernous sinus is the most frequent dural sinus to become infected and thrombosed. The underlying site of infections includes the sphenoid or ethmoid sinuses, facial infections, and dental infections. (See
         <a class="local">
          'Anatomy'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <em>
          Staphylococcus aureus
         </em>
         accounts for 70 percent of all infections and is the etiologic pathogen in nearly all cases associated with facial infection or sphenoid sinusitis. (See
         <a class="local">
          'Microbiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Headache is the most common early symptom and generally precedes fever and periorbital edema by several days. Other common clinical manifestations include eye swelling and diplopia.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         These symptoms are not specific, but the presence of cranial nerve signs (particularly lateral gaze palsy) on physical examination in a patient with headache should alert the clinician to the possibility of the diagnosis and prompt an urgent evaluation.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Magnetic resonance imaging (MRI) with gadolinium is the imaging modality of choice. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above and
         <a class="local">
          'Evaluation and diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Urgent empiric antibiotic therapy is required. For most patients, we suggest a regimen that includes
         <a class="drug drug_general" data-topicid="10037" href="/z/d/drug information/10037.html" rel="external">
          vancomycin
         </a>
         plus
         <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">
          ceftriaxone
         </a>
         or
         <a class="drug drug_general" data-topicid="9215" href="/z/d/drug information/9215.html" rel="external">
          cefepime
         </a>
         (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ).
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          Metronidazole
         </a>
         should be added if anaerobic coverage is required (eg, suspected dental or sinus infection). (See
         <a class="local">
          'Antibiotics'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         We suggest early heparinization in patients with unilateral cavernous sinus thrombosis in order to prevent bilateral extension (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). (See
         <a class="local">
          'Anticoagulation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Surgical drainage of sphenoid sinus infection that has been documented on imaging should be strongly considered and, if done, should be performed emergently. (See
         <a class="local">
          'Surgery'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3051567658">
         <span class="h2">
          Septic lateral sinus thrombosis
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Septic lateral sinus thrombosis most often occurs as a complication of acute or chronic otitis media. Infection is often polymicrobial, containing both aerobes and anaerobes, reflecting the bacteriology of chronic otitis media. (See
         <a class="local">
          'Pathogenesis'
         </a>
         above and
         <a class="local">
          'Microbiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Along with symptoms of ear infection, patients develop headache along with neurologic signs such as vertigo and fifth and sixth nerve impairment. Some patients develop increased intracranial pressure. (See
         <a class="local">
          'Clinical manifestations'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The diagnosis of septic lateral sinus thrombosis is made by contrast-enhanced MRI. Other essential tests include lumbar puncture and blood cultures. (See
         <a class="local">
          'Evaluation and diagnosis'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Treatment consists of antibiotic therapy and surgery in most cases; some patients require management of elevated intracranial pressure:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Urgent empiric antibiotic therapy is required. For most patients, we suggest a regimen that includes
         <a class="drug drug_general" data-topicid="9646" href="/z/d/drug information/9646.html" rel="external">
          metronidazole
         </a>
         plus either
         <a class="drug drug_general" data-topicid="9229" href="/z/d/drug information/9229.html" rel="external">
          ceftriaxone
         </a>
         or
         <a class="drug drug_general" data-topicid="9215" href="/z/d/drug information/9215.html" rel="external">
          cefepime
         </a>
         (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ).
         <a class="drug drug_general" data-topicid="9613" href="/z/d/drug information/9613.html" rel="external">
          Meropenem
         </a>
         is an acceptable alternative. (See
         <a class="local">
          'Antibiotics'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         In addition, we recommend surgical treatment unless the patient responds rapidly to antibiotic treatment within 12 to 24 hours (
         <a class="grade" href="https:///uptodate/show/grade_3" rel="external">
          Grade 1C
         </a>
         ). (See
         <a class="local">
          'Surgery'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         We suggest against anticoagulation in most patients with lateral sinus thrombosis, unless a hypercoagulable state is documented (
         <a class="grade" href="https:///uptodate/show/grade_6" rel="external">
          Grade 2C
         </a>
         ). However, in patients not responding to antibiotic and surgical treatment, it is reasonable to provide anticoagulation treatment along with monitoring for hemorrhagic complications of anticoagulation. (See
         <a class="local">
          'Anticoagulation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         For patients with increased intracranial pressure, monitoring and interventions are guided by the clinical examination. (See
         <a class="medical medical_review" href="/z/d/html/1659.html" rel="external">
          "Evaluation and management of elevated intracranial pressure in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2743820259">
         <span class="h2">
          Septic superior sagittal sinus thrombosis
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Septic superior sinus thrombosis is a rare complication of bacterial meningitis, bacterial sinusitis, and facial surgery. Producing hemorrhagic infarcts with cerebral edema, along with hydrocephalus, transtentorial brainstem herniation generally ensues, accounting for this condition's high mortality. (See
         <a class="local">
          'Septic superior sagittal sinus thrombosis'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Ferro JM, Canhão P, Bousser MG, et al. Cerebral vein and dural sinus thrombosis in elderly patients. Stroke 2005; 36:1927.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Southwick FS, Richardson EP Jr, Swartz MN. Septic thrombosis of the dural venous sinuses. Medicine (Baltimore) 1986; 65:82.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khatri IA, Wasay M. Septic cerebral venous sinus thrombosis. J Neurol Sci 2016; 362:221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harris FS, Rhoton AL. Anatomy of the cavernous sinus. A microsurgical study. J Neurosurg 1976; 45:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Weerasinghe D, Lueck CJ. Septic Cavernous Sinus Thrombosis: Case Report and Review of the Literature. Neuroophthalmology 2016; 40:263.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hsu CW, Tsai WC, Lien CY, et al. The clinical characteristics, implicated pathogens and therapeutic outcomes of culture-proven septic cavernous sinus thrombosis. J Clin Neurosci 2019; 68:111.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lew D, Southwick FS, Montgomery WW, et al. Sphenoid sinusitis. A review of 30 cases. N Engl J Med 1983; 309:1149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sadun F, Feldon SE, Weiss MH, Krieger MD. Septic cavernous sinus thrombosis following transsphenoidal craniotomy. Case report. J Neurosurg 1996; 85:949.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kahn JB, Baharestani S, Beck HC, et al. Orbital dissemination of Lemierre syndrome from gram-positive septic emboli. Ophthal Plast Reconstr Surg 2011; 27:e67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Park SN, Yeo SW, Suh BD. Cavernous sinus thrombophlebitis secondary to petrous apicitis: a case report. Otolaryngol Head Neck Surg 2003; 128:284.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dubey SP, Larawin V, Molumi CP. Intracranial spread of chronic middle ear suppuration. Am J Otolaryngol 2010; 31:73.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cannon ML, Antonio BL, McCloskey JJ, et al. Cavernous sinus thrombosis complicating sinusitis. Pediatr Crit Care Med 2004; 5:86.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Watkins LM, Pasternack MS, Banks M, et al. Bilateral cavernous sinus thromboses and intraorbital abscesses secondary to Streptococcus milleri. Ophthalmology 2003; 110:569.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Westhout F, Hasso A, Jalili M, et al. Lemierre syndrome complicated by cavernous sinus thrombosis, the development of subdural empyemas, and internal carotid artery narrowing without cerebral infarction. Case report. J Neurosurg 2007; 106:53.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Naesens R, Ronsyn M, Druwé P, et al. Central nervous system invasion by community-acquired meticillin-resistant Staphylococcus aureus. J Med Microbiol 2009; 58:1247.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bengel D, Susa M, Schreiber H, et al. Early diagnosis of rhinocerebral mucormycosis by cerebrospinal fluid analysis and determination of 16s rRNA gene sequence. Eur J Neurol 2007; 14:1067.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Peter L, Krolak-Salmon P, Pignat JC, et al. [Rhinocerebral mucormycosis]. Rev Neurol (Paris) 2005; 161:214.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chitsaz S, Bagheri J, Mandegar MH, et al. Extensive sino-orbital zygomycosis after heart transplantation: a case report. Transplant Proc 2009; 41:2927.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Devèze A, Facon F, Latil G, et al. Cavernous sinus thrombosis secondary to non-invasive sphenoid aspergillosis. Rhinology 2005; 43:152.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Roh ML, Tuazon CU, Mandler R, et al. Sphenocavernous syndrome associated with Schizophyllum commune infection of the sphenoid sinus. Ophthal Plast Reconstr Surg 2005; 21:71.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levine SR, Twyman RE, Gilman S. The role of anticoagulation in cavernous sinus thrombosis. Neurology 1988; 38:517.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Quisling SV, Mawn LA, Larson TC 3rd. Blindness associated with enlarging mycotic aneurysm after cavernous sinus thrombosis. Ophthalmology 2003; 110:2036.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ebright JR, Pace MT, Niazi AF. Septic thrombosis of the cavernous sinuses. Arch Intern Med 2001; 161:2671.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee JH, Lee HK, Park JK, et al. Cavernous sinus syndrome: clinical features and differential diagnosis with MR imaging. AJR Am J Roentgenol 2003; 181:583.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schuknecht B, Simmen D, Yüksel C, Valavanis A. Tributary venosinus occlusion and septic cavernous sinus thrombosis: CT and MR findings. AJNR Am J Neuroradiol 1998; 19:617.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ellie E, Houang B, Louail C, et al. CT and high-field MRI in septic thrombosis of the cavernous sinuses. Neuroradiology 1992; 34:22.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perlroth J, Kuo M, Tan J, et al. Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature. Arch Intern Med 2008; 168:805.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           von Specht M, Gardella N, Tagliaferri P, et al. Methicillin-resistant Staphylococcus aureus in community-acquired meningitis. Eur J Clin Microbiol Infect Dis 2006; 25:267.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pintado V, Meseguer MA, Fortún J, et al. Clinical study of 44 cases of Staphylococcus aureus meningitis. Eur J Clin Microbiol Infect Dis 2002; 21:864.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Balouch MA, Bajwa RJ, Hassoun A. Successful use of ceftaroline for the treatment of MRSA meningitis secondary to an infectious complication of lumbar spine surgery. J Antimicrob Chemother 2015; 70:624.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gallagher RM, Pizer B, Ellison JA, Riordan FA. Glycopeptide insensitive Staphylococcus aureus subdural empyema treated with linezolid and rifampicin. J Infect 2008; 57:410.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kessler AT, Kourtis AP. Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid. Infection 2007; 35:271.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ntziora F, Falagas ME. Linezolid for the treatment of patients with central nervous system infection. Ann Pharmacother 2007; 41:296.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011; 52:e18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Levitz RE, Quintiliani R. Trimethoprim-sulfamethoxazole for bacterial meningitis. Ann Intern Med 1984; 100:881.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vartzelis G, Theodoridou M, Daikos GL, et al. Brain abscesses complicating Staphylococcus aureus sepsis in a premature infant. Infection 2005; 33:36.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bhatia K, Jones NS. Septic cavernous sinus thrombosis secondary to sinusitis: are anticoagulants indicated? A review of the literature. J Laryngol Otol 2002; 116:667.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zuurbier SM, Coutinho JM, Stam J, et al. Clinical Outcome of Anticoagulant Treatment in Head or Neck Infection-Associated Cerebral Venous Thrombosis. Stroke 2016; 47:1271.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poulopoulos M, Finelli PF. Neurological complications with acute sphenoid sinusitis a surgical emergency? Neurocrit Care 2007; 7:169.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van der Poel NA, Mourits MP, de Win MML, et al. Prognosis of septic cavernous sinus thrombosis remarkably improved: a case series of 12 patients and literature review. Eur Arch Otorhinolaryngol 2018; 275:2387.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Desa V, Green R. Cavernous sinus thrombosis: current therapy. J Oral Maxillofac Surg 2012; 70:2085.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Canhão P, Cortesão A, Cabral M, et al. Are steroids useful to treat cerebral venous thrombosis? Stroke 2008; 39:105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Branson SV, McClintic E, Yeatts RP. Septic Cavernous Sinus Thrombosis Associated With Orbital Cellulitis: A Report of 6 Cases and Review of Literature. Ophthalmic Plast Reconstr Surg 2019; 35:272.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jain A, Arora N, Meher R, et al. Intracranial complications of CSOM in pediatric patients: A persisting problem in developing countries. Int J Pediatr Otorhinolaryngol 2017; 100:128.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seven H, Ozbal AE, Turgut S. Management of otogenic lateral sinus thrombosis. Am J Otolaryngol 2004; 25:329.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Viswanatha B, Thriveni CN, Naseeruddin K. Nonseptic and septic lateral sinus thrombosis: a review. Indian J Otolaryngol Head Neck Surg 2014; 66:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wolfowitz BL. Otogenic intracranial complications. Arch Otolaryngol 1972; 96:220.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Samuel J, Fernandes CM. Lateral sinus thrombosis (a review of 45 cases). J Laryngol Otol 1987; 101:1227.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Funamura JL, Nguyen AT, Diaz RC. Otogenic lateral sinus thrombosis: case series and controversies. Int J Pediatr Otorhinolaryngol 2014; 78:866.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oestreicher-Kedem Y, Raveh E, Kornreich L, et al. Prothrombotic factors in children with otitis media and sinus thrombosis. Laryngoscope 2004; 114:90.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Manolidis S, Kutz JW Jr. Diagnosis and management of lateral sinus thrombosis. Otol Neurotol 2005; 26:1045.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dubey SP, Larawin V. Complications of chronic suppurative otitis media and their management. Laryngoscope 2007; 117:264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scorpecci A, Massoud M, Giannantonio S, et al. Otogenic lateral sinus thrombosis in children: proposal of an experience-based treatment flowchart. Eur Arch Otorhinolaryngol 2018; 275:1971.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Scardapane A, Del Torto M, Nozzi M, et al. Gradenigo's syndrome with lateral venous sinus thrombosis: successful conservative treatment. Eur J Pediatr 2010; 169:437.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valles JM, Fekete R. Gradenigo syndrome: unusual consequence of otitis media. Case Rep Neurol 2014; 6:197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rollins N, Ison C, Reyes T, Chia J. Cerebral MR venography in children: comparison of 2D time-of-flight and gadolinium-enhanced 3D gradient-echo techniques. Radiology 2005; 235:1011.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong BY, Hickman S, Richards M, et al. Management of paediatric otogenic cerebral venous sinus thrombosis: a systematic review. Clin Otolaryngol 2015; 40:704.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schneider S, Kapelushnik J, Kraus M, et al. The association between otogenic lateral sinus thrombosis and thrombophilia - A long-term follow-up. Am J Otolaryngol 2018; 39:299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seid AB, Sellars SL. The management of otogenic lateral sinus disease at Groote Schuur Hospital. Laryngoscope 1973; 83:397.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh B. The management of lateral sinus thrombosis. J Laryngol Otol 1993; 107:803.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Syms MJ, Tsai PD, Holtel MR. Management of lateral sinus thrombosis. Laryngoscope 1999; 109:1616.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ghosh PS, Ghosh D, Goldfarb J, Sabella C. Lateral sinus thrombosis associated with mastoiditis and otitis media in children: a retrospective chart review and review of the literature. J Child Neurol 2011; 26:1000.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agarwal A, Lowry P, Isaacson G. Natural history of sigmoid sinus thrombosis. Ann Otol Rhinol Laryngol 2003; 112:191.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Singh GB, Arora R, Garg S, et al. Septic Lateral Sinus Thrombosis: Sinus Exploration Is Unnecessary. Case Rep Otolaryngol 2016; 2016:4349538.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong I, Kozak FK, Poskitt K, et al. Pediatric lateral sinus thrombosis: retrospective case series and literature review. J Otolaryngol 2005; 34:79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shah UK, Jubelirer TF, Fish JD, Elden LM. A caution regarding the use of low-molecular weight heparin in pediatric otogenic lateral sinus thrombosis. Int J Pediatr Otorhinolaryngol 2007; 71:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Au JK, Adam SI, Michaelides EM. Contemporary management of pediatric lateral sinus thrombosis: a twenty year review. Am J Otolaryngol 2013; 34:145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sifri CD, Solenski N. Fatal septic thrombosis of the superior sagittal sinus after face-lift surgery caused by community-associated methicillin-resistant Staphylococcus aureus. Arch Facial Plast Surg 2009; 11:142.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strauss SI, Stern NS, Mendelow H, Spatz SS. Septic superior sagittal sinus thrombosis after oral surgery. J Oral Surg 1973; 31:560.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Canhão P, Ferro JM, Lindgren AG, et al. Causes and predictors of death in cerebral venous thrombosis. Stroke 2005; 36:1720.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haroun A. Utility of contrast-enhanced 3D turbo-flash MR angiography in evaluating the intracranial venous system. Neuroradiology 2005; 47:322.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 3410 Version 28.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16100024" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Cerebral vein and dural sinus thrombosis in elderly patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3512953" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Septic thrombosis of the dural venous sinuses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26944152" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Septic cerebral venous sinus thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/939976" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Anatomy of the cavernous sinus. A microsurgical study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27928417" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Septic Cavernous Sinus Thrombosis: Case Report and Review of the Literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31331748" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : The clinical characteristics, implicated pathogens and therapeutic outcomes of culture-proven septic cavernous sinus thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6621661" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Sphenoid sinusitis. A review of 30 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8893738" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Septic cavernous sinus thrombosis following transsphenoidal craniotomy. Case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21566465" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Orbital dissemination of Lemierre syndrome from gram-positive septic emboli.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12601329" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Cavernous sinus thrombophlebitis secondary to petrous apicitis: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20015716" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Intracranial spread of chronic middle ear suppuration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14697115" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Cavernous sinus thrombosis complicating sinusitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12623823" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Bilateral cavernous sinus thromboses and intraorbital abscesses secondary to Streptococcus milleri.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17233314" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Lemierre syndrome complicated by cavernous sinus thrombosis, the development of subdural empyemas, and internal carotid artery narrowing without cerebral infarction. Case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19528145" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Central nervous system invasion by community-acquired meticillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17718704" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Early diagnosis of rhinocerebral mucormycosis by cerebrospinal fluid analysis and determination of 16s rRNA gene sequence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15798521" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : [Rhinocerebral mucormycosis].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19765477" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Extensive sino-orbital zygomycosis after heart transplantation: a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16008074" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Cavernous sinus thrombosis secondary to non-invasive sphenoid aspergillosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15677958" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Sphenocavernous syndrome associated with Schizophyllum commune infection of the sphenoid sinus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3281056" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : The role of anticoagulation in cavernous sinus thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14522784" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Blindness associated with enlarging mycotic aneurysm after cavernous sinus thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11732931" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Septic thrombosis of the cavernous sinuses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12876052" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Cavernous sinus syndrome: clinical features and differential diagnosis with MR imaging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9576645" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Tributary venosinus occlusion and septic cavernous sinus thrombosis: CT and MR findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1553033" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : CT and high-field MRI in septic thrombosis of the cavernous sinuses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18443255" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Adjunctive use of rifampin for the treatment of Staphylococcus aureus infections: a systematic review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16570137" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Methicillin-resistant Staphylococcus aureus in community-acquired meningitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12525921" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Clinical study of 44 cases of Staphylococcus aureus meningitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25274007" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Successful use of ceftaroline for the treatment of MRSA meningitis secondary to an infectious complication of lumbar spine surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18703232" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Glycopeptide insensitive Staphylococcus aureus subdural empyema treated with linezolid and rifampicin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17646913" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Treatment of meningitis caused by methicillin-resistant Staphylococcus aureus with linezolid.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17284501" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Linezolid for the treatment of patients with central nervous system infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21208910" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6372565" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Trimethoprim-sulfamethoxazole for bacterial meningitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15750759" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Brain abscesses complicating Staphylococcus aureus sepsis in a premature infant.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12437798" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Septic cavernous sinus thrombosis secondary to sinusitis: are anticoagulants indicated? A review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27032446" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Clinical Outcome of Anticoagulant Treatment in Head or Neck Infection-Associated Cerebral Venous Thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17846721" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Neurological complications with acute sphenoid sinusitis a surgical emergency?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29998385" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Prognosis of septic cavernous sinus thrombosis remarkably improved: a case series of 12 patients and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22326173" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Cavernous sinus thrombosis: current therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18063833" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Are steroids useful to treat cerebral venous thrombosis?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30320718" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Septic Cavernous Sinus Thrombosis Associated With Orbital Cellulitis: A Report of 6 Cases and Review of Literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28802356" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Intracranial complications of CSOM in pediatric patients: A persisting problem in developing countries.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15334397" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Management of otogenic lateral sinus thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24533354" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Nonseptic and septic lateral sinus thrombosis: a review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/5081930" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Otogenic intracranial complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3323379" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Lateral sinus thrombosis (a review of 45 cases).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24680135" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Otogenic lateral sinus thrombosis: case series and controversies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14710001" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Prothrombotic factors in children with otitis media and sinus thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16151357" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Diagnosis and management of lateral sinus thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17277619" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Complications of chronic suppurative otitis media and their management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29948264" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Otogenic lateral sinus thrombosis in children: proposal of an experience-based treatment flowchart.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19697060" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Gradenigo's syndrome with lateral venous sinus thrombosis: successful conservative treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25232331" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Gradenigo syndrome: unusual consequence of otitis media.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15860678" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Cerebral MR venography in children: comparison of 2D time-of-flight and gadolinium-enhanced 3D gradient-echo techniques.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26769686" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Management of paediatric otogenic cerebral venous sinus thrombosis: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29530427" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : The association between otogenic lateral sinus thrombosis and thrombophilia - A long-term follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4690031" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : The management of otogenic lateral sinus disease at Groote Schuur Hospital.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8228594" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : The management of lateral sinus thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10522931" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Management of lateral sinus thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21540368" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Lateral sinus thrombosis associated with mastoiditis and otitis media in children: a retrospective chart review and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12597296" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Natural history of sigmoid sinus thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26881164" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Septic Lateral Sinus Thrombosis: Sinus Exploration Is Unnecessary.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16076405" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Pediatric lateral sinus thrombosis: retrospective case series and literature review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17126414" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : A caution regarding the use of low-molecular weight heparin in pediatric otogenic lateral sinus thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23177380" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Contemporary management of pediatric lateral sinus thrombosis: a twenty year review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19289690" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Fatal septic thrombosis of the superior sagittal sinus after face-lift surgery caused by community-associated methicillin-resistant Staphylococcus aureus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4513469" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Septic superior sagittal sinus thrombosis after oral surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16002765" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Causes and predictors of death in cerebral venous thrombosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15846483" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Utility of contrast-enhanced 3D turbo-flash MR angiography in evaluating the intracranial venous system.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
